[8][9][10] Ro raised $3.1 million in a seed funding round led by General Catalyst and launched with a telemedicine practice, in addition to a pharmacy, to distribute medications.

[11] In September 2018, the company renamed itself Ro and expanded its treatment to additional pathologies like hair loss, cold sores, and premature ejaculation.

[12][13] In 2018, Ro raised $88 million in a Series A funding round led by FirstMark Capital, and added Reddit Founder Alexis Ohanian as a board director.

[17] In March 2021, Ro raised $500 million in a series D funding round led by General Catalyst, FirstMark Capital, and TQ Ventures, giving the company a $5 billion valuation.

[34] In December of 2024, Ro announced that they were working with pharmaceutical company Eli Lilly to offer Zepbound vials via the platform through an integration with LillyDirect.

[35] Ro patients fill out a dynamic online visit answering questions about their health, lifestyle, medical history, and symptoms.

[37][38] In October 2022, Ro reached an agreement with the National Institute on Aging to create a registry of patients for future Alzheimer's disease research and clinical trials.

[39] Ro has published research on a variety of telehealth topics, including comparable rates of side effects found with treatment via asynchronous and synchronous virtual care.